Current:Home > reviewsThis drug is the 'breakthrough of the year' — and it could mean the end of the HIV epidemic -Mastery Money Tools
This drug is the 'breakthrough of the year' — and it could mean the end of the HIV epidemic
TrendPulse Quantitative Think Tank Center View
Date:2025-04-06 14:45:24
Can we eliminate the HIV epidemic?
It's a question that dates back to the start of the epidemic in the 1980s. With 1.3 million new infections a year, the epidemic continues … and the world is not on track to meet the ambitious U.N. goal of ending HIV/AIDS by 2030.
But 2024 has fueled increasing optimism among leading infectious disease experts after the results of two groundbreaking clinical trial results for a drug called lenacapavir showed it to be capable of virtually eliminating new HIV infections through sex.
The emerging data surrounding lenacapavir is so astonishing that the drug's development has been heralded as the 2024 Breakthrough of the Year by the journal Science,which described it as representing "a pivotal step toward diminishing HIV/AIDS as a global health crisis."
veryGood! (3949)
Related
- The Best Stocking Stuffers Under $25
- Hong Kong places arrest bounties on activists abroad for breaching national security law
- Retail sales up 0.3% in November, showing how Americans continue to spend
- A leader of Taiwan’s Nationalist Party visits China as the island’s presidential election looms
- Charges tied to China weigh on GM in Q4, but profit and revenue top expectations
- 2023: The year we played with artificial intelligence — and weren’t sure what to do about it
- Father of July 4th Illinois parade shooting suspect released early from jail for good behavior
- 'The Crown' ends as pensive meditation on the most private public family on Earth
- Off the Grid: Sally breaks down USA TODAY's daily crossword puzzle, Hi Hi!
- Retail sales up 0.3% in November, showing how Americans continue to spend
Ranking
- Head of the Federal Aviation Administration to resign, allowing Trump to pick his successor
- From frontline pitchers to warm bodies, a look at every MLB team's biggest need
- Why is Draymond Green suspended indefinitely? His reckless ways pushed NBA to its breaking point
- A Buc-ee's monument, in gingerbread form: How a Texas couple recreated the beloved pitstop
- McKinsey to pay $650 million after advising opioid maker on how to 'turbocharge' sales
- The family of a Chicago woman who died in a hotel freezer agrees to a $10 million settlement
- Germany and Turkey agree to train imams who serve Germany’s Turkish immigrant community in Germany
- The Dodgers are ready to welcome Shohei Ohtani to Hollywood
Recommendation
Apple iOS 18.2: What to know about top features, including Genmoji, AI updates
Court voids fine given to Russian activist for criticizing war and sends case back to prosecutors
Use of Plan B morning after pills doubles, teen sex rates decline in CDC survey
Will the American Geophysical Union Cut All Ties With the Fossil Fuel Industry?
The Best Stocking Stuffers Under $25
Veteran Taj Gibson rejoining New York Knicks, reuniting with Thibodeau
Veteran Taj Gibson rejoining New York Knicks, reuniting with Thibodeau
Who are the Von Erich brothers? What to know about 'The Iron Claw's devastating subject